PD-L1 expression was evaluated on tumor specimens prospectively using the Ventana PD-L1 (SP142) Assay, using the threshold cutoff of more than 5% of the tumor area having PD-L1-positive tumor-infiltrating immune cells (IC) (72). Here, CD274 is linked to neoplasm.